ProPhase Labs, Inc. (PRPH)

USD 0.7

(1.33%)

Market Cap (In USD)

16.59 Million

Revenue (In USD)

44.38 Million

Net Income (In USD)

-16.78 Million

Avg. Volume

32.2 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.64-7.48
PE
-
EPS
-
Beta Value
-0.095
ISIN
US74345W1080
CUSIP
74345W108
CIK
868278
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ted William Karkus
Employee Count
-
Website
https://www.prophaselabs.com
Ipo Date
1994-04-04
Details
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.